Market Insight Proteins, Antibodies & ADCs

De Novo Design Of Oral And Cell-Permeable Peptides Using Generative AI

Hans Melo

Hans Melo

Co-Founder & Chief Executive Officer

Menten AI

15 July, 2026
Watch time: 15 Minutes

Highlights

Takeaways

We present a physics-based generative AI framework for the de novo design of cyclic peptides that exhibit both passive membrane permeability and high target affinity. As a case study, we describe the application of Menten AI’s design platform to generate cyclic peptides against a difficult protein–protein interaction target.

Hans Melo, Chief Executive Officer, Menten AI

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.